Blue Note Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Blue note therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Blue Note Therapeutics Inc Today - Breaking & Trending Today

Blue Note Therapeutics Raises $26.25 Million in Series A Financing


Share this article
Share this article
SAN FRANCISCO, March 3, 2021 /PRNewswire/  Blue Note Therapeutics, Inc., today announced the closing of a Series A financing round of $26.25 million. Proceeds will allow the company to scale the organization and fund near-term clinical trials of its lead prescription digital therapeutic (PDT), which will potentially improve the treatment of cancer. The capital will also support the development of Blue Note s pipeline assets. The Series A financing was led by JAZZ Venture Partners and joined by Summer VC.
Blue Note Therapeutics is dedicated to serving patients suffering from cancer-related distress. Working closely with leading cancer research centers and patient communities, Blue Note is developing clinically validated medical devices designed to improve overall cancer outcomes. These products will help address the specific psychosocial needs of oncology patients and may reduce comorbidities such as anxiety, depression, and fear ....

United States , Geoffrey Eich , Andrew Firlik , Porter Novelli , Centers For Disease , Drug Administration , University Of Miami , Blue Note Therapeutics Inc , Memorial Sloan Kettering Cancer Center , National Comprehensive Cancer Network , American Cancer Society , Blue Note Therapeutics , Blue Note , Note Therapeutics , Managing Partner , Massachusetts General Hospital , Breakthrough Device Designation , Prescription Digital Therapeutics , Cancer Facts , Disease Control , Depression Medicine Use Among Cancer , Comprehensive Cancer , Distress Management , Practice Guidelines , Cancer Related , Cancer Treatment ,

Blue Note Therapeutics Partnering with Patient Advocacy Groups to Provide Digital Cancer-Related Mental Health Care During Pandemic


Published: Jan 08, 2021
 
SAN FRANCISCO, Jan. 8, 2021 /PRNewswire/ Nearly all cancer patients face fear, anxiety, and uncertainty following diagnosis and treatment. Cancer-related distress can impact a patient s emotional and physical well-being, which for many has been further compounded by the COVID-19 pandemic. Founded by a team of biotech veterans, Blue Note Therapeutics, Inc., is leveraging deep scientific and clinical expertise, neuroscience, and digital innovation to make mental health care available to any cancer patient at any time. In 2020, the company launched
COVID Cancer Care, a digital program intended to help adults with cancer cope with stress and anxiety related to the COVID-19 pandemic. ....

United States , Geoffrey Eich , Porter Novelli , Kim Thiboldeaux , Centers For Disease , Drug Administration , University Of Miami , Cancer Support Community , Blue Note Therapeutics Inc , National Comprehensive Cancer Network , American Cancer Society , Blue Note Therapeutics , Blue Note , Cancer Support , Blue Note Therapeutic , Breakthrough Device Designation , Note Therapeutics , Cancer Facts , Disease Control , Depression Medicine Use Among Cancer , Comprehensive Cancer , Distress Management , Practice Guidelines , Cancer Related , Cancer Treatment , Survivorship Facts ,